Clinical Trial Update: A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase III trial of SYHX1901 tablets for moderate to severe plaque psoriasis has not yet begun recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SYHX1901

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Moderate to Severe Plaque Psoriasis | Phase 3 | Status: NOT_YET_RECRUITING